JEFFREY VIAR: Open Payments
NPI 1811998271 · COLUMBUS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 14 payments from 11 companies in 2025. Trend: 2023 $1,525 · 2024 $2,036 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $75 |
| Novo Nordisk Inc | 1 | $50 |
| Boston Scientific Corporation | 2 | $34 |
| Amgen Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: TRELEGY ELLIPTA, Wegovy, WATCHMAN FLX, JARDIANCE, EVENITY, FARXIGA, LEQVIO, AJOVY.
Industry payments across NC — which companies pay providers there.
